Recent trends in preclinical drug–drug interaction studies of flavonoids — Review of case studies, issues and perspectives

Publisher： John Wiley & Sons Inc

E-ISSN： 1099-1573|29|11|1679-1691

ISSN： 0951-418x

Source： PHYTOTHERAPY RESEARCH, Vol.29, Iss.11, 2015-11, pp. : 1679-1691

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ritonavir is the best alternative to ketoconazole as an index inhibitor of cytochrome P450‐3A in drug–drug interaction studies

By  

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 80, Iss. 3, 2015-09 ,pp. : 342-350

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effects of Strong CYP3A Inhibition and Induction on the Pharmacokinetics of Ixazomib, an Oral Proteasome Inhibitor: Results of Drug‐Drug Interaction Studies in Patients With Advanced Solid Tumors or Lymphoma and a Physiologically Based Pharmacokinetic Analysis

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 58, Iss. 2, 2018-02 ,pp. : 180-192

John Wiley & Sons Inc

Access to resources Recommend Favorite

Recent Trends in Drug Treatment in Europe

By  

European Addiction Research, Vol. 5, Iss. 3, 1999-08 ,pp. : 145-152

Karger

Access to resources Recommend Favorite

Transporter‐Mediated Drug–Drug Interactions Involving OATP Substrates: Predictions Based on In Vitro Inhibition Studies

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 91, Iss. 6, 2012-06 ,pp. : 1053-1064

John Wiley & Sons Inc

Access to resources Recommend Favorite

Methadone: a review of drug-drug and pathophysiological interactions

By Kapur Bhushan M.   Hutson Janine R.   Chibber Tamanna   Luk Adriana   Selby Peter  

Critical Reviews in Clinical Laboratory Sciences, Vol. 48, Iss. 4, 2011-08 ,pp. : 171-195

Informa Healthcare

Access to resources Recommend Favorite